Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-08 08:33 am Purchase | 2024-09-30 | 13G | SELLAS Life Sciences Group, Inc. SLS | Highbridge Capital Management, LLC | 13,264,712 9.900% | 11,184,658 (+537.71%) | Filing History |
| 2024-02-07 3:01 pm Purchase | 2023-12-31 | 13G | SELLAS Life Sciences Group, Inc. SLS | Highbridge Capital Management, LLC | 2,080,054 6.500% | 2,080,054 (New Position) | Filing History |
| 2021-02-16 10:08 am Sale | 2020-12-31 | 13G | SELLAS Life Sciences Group, Inc. SLS | CVI Investments, Inc. | 315,249 2.700% | -259,135 (-45.12%) | Filing History |
| 2021-02-12 4:05 pm Sale | 2020-12-31 | 13G | SELLAS Life Sciences Group, Inc. SLS | PACKER PAUL | 141,553 1.200% | -355,838 (-71.54%) | Filing History |
| 2020-12-14 07:15 am Sale | 2020-12-11 | 13G | SELLAS Life Sciences Group, Inc. SLS | Orin Hirschman | 190,000 1.500% | -746,735 (-79.72%) | Filing History |
| 2020-09-21 09:00 am Purchase | 2020-09-17 | 13G | SELLAS Life Sciences Group, Inc. SLS | PACKER PAUL | 497,391 5.300% | 497,391 (New Position) | Filing History |
| 2020-08-25 09:02 am Purchase | 2020-08-03 | 13G | SELLAS Life Sciences Group, Inc. SLS | Orin Hirschman | 936,735 9.900% | 936,735 (New Position) | Filing History |
| 2020-02-14 4:52 pm Sale | 2019-12-31 | 13G | SELLAS Life Sciences Group, Inc. SLS | Anson Funds Management LP | 0 0.000% | -100,000 (Position Closed) | Filing History |
| 2020-02-14 1:18 pm Sale | 2019-12-31 | 13G | SELLAS Life Sciences Group, Inc. SLS | Altium Capital Management LP | 56,000 1.100% | -277,332 (-83.20%) | Filing History |
| 2020-02-13 11:44 am Unchanged | 2019-12-31 | 13G | SELLAS Life Sciences Group, Inc. SLS | Renaissance Technologies LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2020-02-13 09:57 am Purchase | 2019-12-31 | 13G | SELLAS Life Sciences Group, Inc. SLS | 683 Capital Management LLC | 38,000 1.000% | 12,500 (+49.02%) | Filing History |